These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19036061)

  • 21. Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels.
    Marcucci R; Abbate R; Fedi S; Gori AM; Brunelli T; Bruni V; Bucciantini S; Micheli S; Pepe G; Prisco D; Gensini GF
    Am J Clin Pathol; 1999 Jun; 111(6):769-72. PubMed ID: 10361512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for activated protein C resistance before oral contraceptive treatment: a pilot study.
    Palareti G; Legnani C; Frascaro M; Flamigni C; Gammi L; Gola G; Fuschini G; Coccheri S
    Contraception; 1999 May; 59(5):293-9. PubMed ID: 10494482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception.
    Tanratana P; Ellery P; Westmark P; Mast AE; Sheehan JP
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):266-274. PubMed ID: 29097362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of acquired activated protein C resistance and D-dimer in breast cancer.
    Tinholt M; Sandset PM; Mowinckel MC; Garred Ø; Sahlberg KK; Kristensen VN; Børresen-Dale AL; Jacobsen AF; Skretting G; Iversen N
    Thromb Res; 2016 Sep; 145():78-83. PubMed ID: 27505249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to activated protein C in healthy women taking oral contraceptives.
    Olivieri O; Friso S; Manzato F; Guella A; Bernardi F; Lunghi B; Girelli D; Azzini M; Brocco G; Russo C
    Br J Haematol; 1995 Oct; 91(2):465-70. PubMed ID: 8547095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism.
    Arafat A; Gennari P; Ignatov A; Tchaikovski S
    Blood Coagul Fibrinolysis; 2023 Jun; 34(4):233-238. PubMed ID: 37115963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APC resistance: biological basis and acquired influences.
    Castoldi E; Rosing J
    J Thromb Haemost; 2010 Mar; 8(3):445-53. PubMed ID: 20002539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women.
    Tans G; van Hylckama Vlieg A; Thomassen MC; Curvers J; Bertina RM; Rosing J; Rosendaal FR
    Br J Haematol; 2003 Aug; 122(3):465-70. PubMed ID: 12877675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes.
    Segers O; Simioni P; Tormene D; Bulato C; Gavasso S; Rosing J; Castoldi E
    J Thromb Haemost; 2012 Jan; 10(1):73-80. PubMed ID: 22044617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.
    Heinemann LA; Assmann A; Spannagl M; Schramm W; Dick A; Kluft C; de Maat MP
    Contraception; 1998 Nov; 58(5):321-2. PubMed ID: 9883389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial.
    Høibraaten E; Mowinckel MC; de Ronde H; Bertina RM; Sandset PM
    Br J Haematol; 2001 Nov; 115(2):415-20. PubMed ID: 11703344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of factor V Leiden, oral contraceptive use, type of oral contraceptives and pregnancy on APC-r levels in women with or without a history of pre-eclampsia.
    Bloemenkamp KW; de Groot CJ; Ronde HD; Duvekot EJ; Helmerhorst FM; Bertina RM
    Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):225. PubMed ID: 11301177
    [No Abstract]   [Full Text] [Related]  

  • 33. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
    Dahlbäck B
    Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a calibrated automated thrombography based thrombin generation test in mouse plasma.
    Tchaikovski SN; VAN Vlijmen BJ; Rosing J; Tans G
    J Thromb Haemost; 2007 Oct; 5(10):2079-86. PubMed ID: 17666016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the plasma levels of protein C system parameters in pregnancy.
    Vodnik T; Ignjatović S; Majkić-Singh N
    Scand J Clin Lab Invest; 2003; 63(7-8):481-8. PubMed ID: 14743957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.
    Castoldi E; Brugge JM; Nicolaes GA; Girelli D; Tans G; Rosing J
    Blood; 2004 Jun; 103(11):4173-9. PubMed ID: 14976057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.
    Simioni P; Scarano L; Gavasso S; Sardella C; Girolami B; Scudeller A; Girolami A
    Br J Haematol; 1996 Feb; 92(2):435-41. PubMed ID: 8603014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced factor V concentration and altered FV1/FV2 ratio do not fully explain R2-associated APC-resistance.
    Govers-Riemslag JW; Castoldi E; Nicolaes GA; Tans G; Rosing J
    Thromb Haemost; 2002 Sep; 88(3):444-9. PubMed ID: 12353074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.